Register entry

TheracosBio, LLC

Data as of · How to read this entry

Registered sites
0
Active NDC listings
2
Live patents
7
Exclusivities
1
Countries
0
Catalogue

Drug listings by form and route

2

2 active NDC listings: 2 human prescription drug. By marketing category: NDA 1, NDA AUTHORIZED GENERIC 1.

Dosage formNDCs
tablet2
RouteNDCs
oral2
Labeller name on the listingNDCs
theracosbio, llc2
Exclusivity

Patents and exclusivities

7
PatentProductCoversExpiry
8106021BRENZAVVYbexagliflozinuseAug 2028
8802637BRENZAVVYbexagliflozinsubstance, productAug 2028
7838499BRENZAVVYbexagliflozinsubstance, productJan 2029
10981942BRENZAVVYbexagliflozinsubstance, productJun 2031
10533032BRENZAVVYbexagliflozinuseJul 2031
8987323BRENZAVVYbexagliflozinsubstance, productMay 2032
12594243BRENZAVVYbexagliflozinproductOct 2041
ProductExclusivityUntil
BRENZAVVYBEXAGLIFLOZINNCE New chemical entityJan 2028
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
BRENZAVVYBexagliflozintablet, oral82381-2174NDA
BexagliflozinBexagliflozintablet, oral82381-2000NDA AUTHORIZED GENERIC
Compare

Other companies listing bexagliflozin

Enquiry

Common questions

Is TheracosBio, LLC FDA approved?
TheracosBio, LLC holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does TheracosBio, LLC make?
2 products are listed under TheracosBio, LLC in the openFDA NDC Directory, most often as tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.